Protagen Deepens Cooperation with Bayer Schering Pharma

News   Jun 10, 2010

 
Protagen Deepens Cooperation with Bayer Schering Pharma
 
 
 

RELATED ARTICLES

Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast Cancer

News

A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.

READ MORE

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

Fraunhofer and Mologic Partner on Point-of-Care Diagnosis and Antibiotic Susceptibility Test for UTIs

News

Test will allow better targeting of prescription antibiotics and address growing antimicrobial resistance.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE